SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001385508-22-000015
Filing Date
2022-01-07
Accepted
2022-01-07 16:02:20
Documents
12
Period of Report
2022-01-04
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K opnt-20220104.htm   iXBRL 8-K 39683
  Complete submission text file 0001385508-22-000015.txt   180114

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT opnt-20220104.xsd EX-101.SCH 1896
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT opnt-20220104_lab.xml EX-101.LAB 24849
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT opnt-20220104_pre.xml EX-101.PRE 13042
6 EXTRACTED XBRL INSTANCE DOCUMENT opnt-20220104_htm.xml XML 11825
Mailing Address 233 WILSHIRE BLVD, SUITE 280 SUITE 500 SANTA MONICA CA 90401
Business Address 233 WILSHIRE BLVD, SUITE 280 SUITE 500 SANTA MONICA CA 90401 (310) 598-5410
OPIANT PHARMACEUTICALS, INC. (Filer) CIK: 0001385508 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38193 | Film No.: 22518148
SIC: 2834 Pharmaceutical Preparations